One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Challenges and opportunities in the management of acute heart failure and cardiac amyloidosis
Filippo Crea
doi : 10.1093/eurheartj/ehad403
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2135–2139
Rediscovery of magnetocardiography for diagnostic screening and monitoring of treatment response in cardiology
Bettina Heidecker
doi : 10.1093/eurheartj/ehad213
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2140–2142
Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease research
Miron Sopic, Georgios Kararigas, Yvan Devaux, Paolo Magni
doi : 10.1093/eurheartj/ehad153
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2143–2145
Reviewers List 2022
doi : 10.1093/eurheartj/ehad157
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2146–2156
Intravascular imaging to guide percutaneous coronary intervention of complex lesions: time to renovate guidelines?
Rocco Vergallo, Giovanna Liuzzo
doi : 10.1093/eurheartj/ehad243
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2157–2158
Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice
Wilfried Mullens, Paul Christian Schulze, Julian Westphal, Jürgen Bogoviku, Johann Bauersachs
doi : 10.1093/eurheartj/ehad266
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2159–2169
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER
Jawad H Butt, Toru Kondo, Mingming Yang, Pardeep S Jhund, Kieran F Docherty, Muthiah Vaduganathan, Brian L Claggett, Adrian F Hernandez, Carolyn S P Lam, Silvio E Inzucchi, Felipe A Martinez, Rudolf A de Boer, Mikhail N Kosiborod, Akshay S Desai, Lars Køber, Piotr Ponikowski, Marc S Sabatine, Sanjiv J Shah, Natalia Zaozerska, Ulrica Wilderäng, Olof Bengtsson, Scott D Solomon, John J V McMurray
doi : 10.1093/eurheartj/ehad276
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2170–2183
Because an increased risk of amputation with canagliflozin was reported in the CANVAS trials, there has been a concern about the safety of sodium–glucose cotransporter 2 inhibitors in patients with peripheral artery disease (PAD) who are at higher risk of amputation.
Good for your heart and safe for your toes: a patient-level meta-analysis of DAPA-HF and DELIVER
Clare Arnott, Bruce Neal
doi : 10.1093/eurheartj/ehad315
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2184–2186
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis
Muhammad Umaid Rauf, Philip N Hawkins, Francesco Cappelli, Federico Perfetto, Mattia Zampieri, Alessia Argiro, Aviva Petrie, Steven Law, Aldostefano Porcari, Yousuf Razvi, Joshua Bomsztyk, Sriram Ravichandran, Adam Ioannou, Rishi Patel, Neasa Starr, David F Hutt, Shameem Mahmood, Brendan Wisniowski, Ana Martinez–Naharro, Lucia Venneri, Carol Whelan, Dorota Roczenio, Janet Gilbertson, Helen J Lachmann, Ashutosh D Wechalekar, Claudio Rapezzi, Matteo Serenelli, Paolo Massa, Angelo Giuseppe Caponetti, Alberto Ponziani, Antonella Accietto, Alessandro Giovannetti, Giulia Saturi, Maurizio Sguazzotti, Christian Gagliardi, Elena Biagini, Simone Longhi, Marianna Fontana, Julian D Gillmore
doi : 10.1093/eurheartj/ehad139
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2187–2198
To perform evaluation of widely embraced bone scintigraphy-based non-biopsy diagnostic criteria (NBDC) for ATTR amyloid cardiomyopathy (ATTR-CM) in clinical practice, and to refine serum free light chain (sFLC) ratio cut-offs that reliably exclude monoclonal gammopathy (MG) in chronic kidney disease.
Expanding indications for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy
Sharmila Dorbala
doi : 10.1093/eurheartj/ehad281
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2199–2201
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial
Paolo Tolomeo, Jawad H Butt, Toru Kondo, Gianluca Campo, Akshay S Desai, Pardeep S Jhund, Lars Køber, Martin P Lefkowitz, Jean L Rouleau, Scott D Solomon, Karl Swedberg, Muthiah Vaduganathan, Michael R Zile, Milton Packer, John J V McMurray
doi : 10.1093/eurheartj/ehad210
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2202–2212
The 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation combining creatinine and cystatin C provides a better estimation of glomerular filtration rate (GFR) compared to the creatinine-only equation.
Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure
Kevin Damman
doi : 10.1093/eurheartj/ehad284
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2213–2215
Sodium–glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study
Edouard L Fu, Elisabetta Patorno, Brendan M Everett, Muthiah Vaduganathan, Scott D Solomon, Raisa Levin, Sebastian Schneeweiss, Rishi J Desai
doi : 10.1093/eurheartj/ehad273
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2216–2230
The effectiveness of sodium–glucose cotransporter 2 inhibitors (SGLT2i) in patients with heart failure (HF) in routine clinical practice is not extensively studied. This study aimed to evaluate the comparative effectiveness of SGLT2i vs.
SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world
Nikolaus Marx, Dirk Müller-Wieland
doi : 10.1093/eurheartj/ehad282
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2231–2233
COVID-19 vaccination-related myocarditis: a Korean nationwide study
Jae Yeong Cho, Kye Hun Kim, Nuri Lee, Soo Hyeon Cho, Seung Yun Kim, Eun Kyoung Kim, Jae-Hyeong Park, Eui-Young Choi, Jin-Oh Choi, Hyukjin Park, Hyung Yoon Kim, Hyun Ju Yoon, Youngkeun Ahn, Myung Ho Jeong, Jeong Gwan Cho
doi : 10.1093/eurheartj/ehad339
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2234–2243,
A comprehensive nationwide study on the incidence and outcomes of COVID-19 vaccination-related myocarditis (VRM) is in need.
Takotsubo syndrome is a coronary microvascular disease: experimental evidence
Feng Dong, Liya Yin, Hamayak Sisakian, Tatevik Hakobyan, Lacey S Jeong, Hirva Joshi, Ellianna Hoff, Selena Chandler, Geetika Srivastava, Abdur Rahman Jabir, Kelly Kimball, Yeong-Renn Chen, Chwen-Lih Chen, Patrick T Kang, Parisa Shabani, Lindsay Shockling, Thomas Pucci, Karlina Kegecik, Christopher Kolz, Zhenyu Jia, William M Chilian, Vahagn Ohanyan
doi : 10.1093/eurheartj/ehad274
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2244–2253
Takotsubo syndrome (TTS) is a conundrum without consensus about the cause. In a murine model of coronary microvascular dysfunction (CMD), abnormalities in myocardial perfusion played a key role in the development of TTS.
Is Takotsubo syndrome just the tip of the iceberg in the clinical spectrum of coronary microvascular dysfunction?
Alessandro Candreva, Christian Templin
doi : 10.1093/eurheartj/ehad264
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2254–2256
To screen or not to screen: that is the question!
Carl Johann Hansen, Peder Emil Warming, Jacob Tfelt-Hansen
doi : 10.1093/eurheartj/ehad286
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Page 2257
Pre-participation screening for safe sports activity
Domenico Corrado, Alessandro Zorzi, Patrizio Sarto
doi : 10.1093/eurheartj/ehad288
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2258–2259
Increased right amygdala activity during the hyper-acute phase of takotsubo syndrome
Francesco Santoro, Rosaria D'Apollo, Natale Daniele Brunetti
doi : 10.1093/eurheartj/ehad302
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Page 2260
Eisenmenger syndrome combined with pulmonary artery dissecting aneurysm
Hongwei Zhang, Lina Yu, Zihao Li
doi : 10.1093/eurheartj/ehad258
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Page 2261
